tweenvest

Onco-Innovations Limited (NEOE: ONCO)

Health Care · Biotechnology · CA

CA$0.23

+12.50% today · -87.1% 1Y

Public summary
A free snapshot of Onco-Innovations Limited, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Onco-Innovations Limited (NEOE: ONCO) operates in the Biotechnology industry within the Health Care sector. The company is valued at $10.93M and employs 1 people.

Over the last twelve months the share price has lost 87.1%, trading between 0.20 and 1.83.

Tweenvest scores Onco-Innovations Limited across four factors: quality 48/100, value 50/100. Its strongest factor is value.

ONCO price history

Nov 21, 2025 · 1.72Weekly closes 0.20 – 1.72Nov 13, 2026 · 0.23

Key figures

Market cap
$10.93M
Revenue (TTM)
$64.78K
P/E
-1.32
EPS
-0.20
Dividend yield
—
Beta (5Y)
2.91
52-week high
CA$1.83
52-week low
CA$0.20
Avg volume (3M)
—
Shares outstanding
69.22M
Employees
1
Next earnings
—

About Onco-Innovations Limited

Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. The company's lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3'-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology. The company has a strategic collaboration with Nucro-Technics Inc. for the development of bioanalytical methods to support preclinical pharmacokinetic and biodistribution studies. Onco-Innovations Limited is headquartered in Calgary, Canada.

ISIN
CA68237C1059
Listed since
Dec 31, 2024
Exchange
Aequitas Neo Exchange
Currency
CAD
CompanyMarket capPriceDay
Genomtec S.A.WSE: GMT$11.13Mzł2.61-5.62%
Miro Sciences LtdASX: MSX$11.09MAU$0.04+2.44%
Chemomab Therapeutics Ltd.NasdaqCM: CMMB$11.09M$1.53+9.29%
Ceryvyn Therapeutics LimitedASX: CYV$11.07MAU$0.01+20.00%
Genomed Spólka AkcyjnaWSE: GEN$10.92Mzł33.00-12.70%
TScan Therapeutics, Inc.NasdaqGM: TCRX$10.89M$0.16-4.40%
Verici Dx plcAIM: VRCI$10.76M£0.000.00%
TME Pharma N.V.ENXTPA: ALTME$10.42M€0.10-4.72%

Browse every Biotechnology company →